Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients

An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.9K citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Lihong Liu, Sho Iketani, Yicheng Guo et al. · Nature · 2021 · 1.4K citations · Full text

Pharmacy, Immunology, Infectious Diseases +13

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Robert Gottlieb, Carlos Vaca, Roger Paredes et al. · New England Journal of Medicine · 2021 · 1.3K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter

Marcus R. Pereira, Sumit Mohan, David J. Cohen et al. · American Journal of Transplantation · 2020 · 838 citations · Full text

Medicine, Infectious Diseases, Surgery +17

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

Paul Y. Kwo, Parvez Mantry, Eoin Coakley et al. · New England Journal of Medicine · 2014 · 402 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17